Bright Uro’s Post

Clinical evaluation of a lumbar interspinous dynamic stabilization device (the Wallis system) with a 13-year mean follow-up https://t.co/j6d1LV9KwK #EurekaMag

💡 What does the current treatment landscape for lower back pain look like and what are the challenges? Is there a cure for chronic back pain on the horizon? Last week, lower back pain patients, researchers, and medical professionals came together and discussed these matters in light of the iPSpine project.   🌟 iPSpine researchers shared insights from a scientific perspective working on the iPSpine project, and many patients shared their personal experiences suffering from lower back pain. Prof. Marianna Tryfonidou: “Their stories fuel our motivation to further pursuing the first-in-class iPSpine therapy.”   Read all about the patient symposium on our website: ➡ https://lnkd.in/et_u2-E5 #iPSpine #lowerbackpain

🚨 Exclusive Webinar Alert! 🚨 We are excited to announce an exclusive webinar session with Peter Shaw, MD, MBBS, DRCOG, from Durham, NC, USA, organized by Bioventus! Join us as we dive into: 💡 DUROLANE's Clinical Evidence – Review of over 20+ key clinical studies. 💡 The DUROLANE Difference – Learn about its benefits for your practice and osteoarthritis patients. 💡 Appropriate Use Criteria – Best practices for injection techniques and patient selection. Register today - https://lnkd.in/dgXXwQ4k #AMMT #DUROLANE #Bioventus #OrthopedicMedicine #SportsMedicine

Ophthopedia Update:Myopia Control Effect of Repeated Low-Level Red-Light Therapy Combined with Orthokeratology: A Multicenter Randomized Controlled Trial: To investigate the efficacy and safety of repeated low-level red-light(RLRL) therapy combined with orthokeratology(Ortho-k) among the children who, despite undergoing Ortho-k treatment, exhibited an axial elongation of at least 0.50mm over 1 year. #Ophthalmology #ophthotwitter #eyecare

How do outcomes differ for RRD patients at risk of PVR following PPV alone or combined PPV/scleral buckling? #Retina specialists Drs. Xu, Rao, and Blackorby review recent literature on the topic: https://bit.ly/3VktATU

🔬 Why Primary SLT is a Game Changer in Glaucoma Management 🔬 Dr. Paul Singh shares why he's passionate about primary SLT. With challenges like compliance, side effects, and costs from glaucoma drops, SLT offers a better solution. It reduces reliance on drops, improves patient outcomes, and minimizes ocular surface issues. Dr. Inder Singh emphasizes how presenting SLT with confidence and in simple terms can increase patient acceptance. He describes SLT as a quick, safe, and covered procedure that often proves a better first-line treatment than drops. Financial Disclosures: Allergan/Abbvie, Bausch + Lomb, BVI, Elios, Nova Eye, Glaukos, iStar Medical, Lumibird Medical, New World Medical, Sight Sciences, Tarsus #GlaucomaCare #PrimarySLT #EyeHealth #Ophthalmology #iDocSocial #Glaucoma #Ophthalmology

In this video from #ISET2024, vascular surgeon Anahita Dua discusses the CLariTI Study, an observational registry that tracked the clinical progression of #CLTI and incidence of death, amputation, and revascularization attempts over a 1-year period. https://okt.to/1sXg8S

"Bhende-Pathak Hernia" A pediatric patient with a Congenital Right-sided Bochdalek's Hernia with herniation of the appendix in the right thoracic cavity, with a Concurrent Patent Ductus Arteriosus - globally the first such reported and successfully operated case - by Dr. Vishal V. Bhende, assisted by Haryax Pathak at BMPCC ShreeKrishnaHospital Karamsad. The detailed case report will be published in a month or two. 🙌🏻 https://lnkd.in/geAkBCK2

ICYMI: #VisualAbstract: Selective early treatment of patent ductus arteriosus with ibuprofen in preterm infants improves short-term outcomes #StudyGraphics #cardiology

If you missed CUCF have a read to gain some insights into Aviclear.